RecruitingNot ApplicableNCT03686709

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment


Sponsor

University of Tennessee

Enrollment

20 participants

Start Date

Jun 19, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres for treatment of hepatocellular carcinoma (HCC) and other metastatic liver disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is measuring how radiation is delivered during a liver treatment called Y90 radioembolization — a procedure where tiny radioactive beads are placed inside blood vessels feeding a liver tumor — and how much radiation exposure occurs to staff and patients, in order to improve safety and treatment accuracy. **You may be eligible if...** - You are already scheduled to receive Y90 radioembolization treatment for a liver condition or liver tumor - You can tolerate an additional PET/CT scan after your treatment - You can tolerate a few extra blood draws before, during, and after the procedure - You can remain at the hospital for the additional imaging after treatment **You may NOT be eligible if...** - You are not a candidate for Y90 radioembolization - You cannot tolerate additional imaging or blood draws - Your schedule does not allow you to stay for the extra scan after treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPost therapy PET/CT Imaging

whole-body PET/CT following Y90 radioembolization


Locations(1)

University of Tennessee Medical Center

Knoxville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03686709


Related Trials